Marijuana is prescribed to help ease chronic pain and control nausea in cancer patients, but legal red tape has made more ...

The order to place cannabis in the same category as Tylenol with codeine marks the most significant change in US drug policy ...

The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses ...

Move doesn’t federally legalize marijuana but would ease tax burdens for cannabis businesses and facilitate more medical ...

I think we’ll see a big shift, with more people willing to try [cannabis] for the first time and see how beneficial it really ...

President Trump signed executive order reclassifying cannabis from Schedule 1 to Schedule 3, expanding research opportunities amid mixed congressional reactions.

Executive order directs federal agencies to expedite a reclassification of cannabis from a Schedule I to a Schedule III drug.

Trump's executive order to expedite reclassifying cannabis means wider access to marijuana, and that it could be used like ...

The federal government has been exaggerating marijuana’s hazards and ignoring its potential benefits for more than half a ...

President Trump issued an executive order calling on the DEA to reclassify cannabis as a Schedule III controlled substance.